Chugai Pharma Taiwan clinical trials
Acquired by Hoffmann-La Roche, Oct 1, 2002 · source ↗
The registry lists 3 studies whose lead sponsor is Chugai Pharma Taiwan. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 5, 2014.
- 3studies on the registry
- 0open to participants now
Before and after it joined Hoffmann-La Roche
- First submitted before Chugai Pharma Taiwan became part of Hoffmann-La Roche
- 0
- First submitted after Chugai Pharma Taiwan became part of Hoffmann-La Roche
- 3
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
What it is testing
The drugs Chugai Pharma Taiwan’s studies test, most studies first; none is open now — 3 drugs with a page of their own. Each count opens the studies in search.
Studies, none open
- Methotrexate2 in phase 30 open · 2
- tocilizumab2 in phase 30 open · 2
- 0 open · 1
All 3 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Completed3100%
Over the years
- 107
- 08
- 09
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 026
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
- Chugai Pharma Taiwan3 studies
Something wrong with this grouping? Tell us on the Hoffmann-La Roche page.
Studies
Recruiting first, then most recently updated. Showing 3 of 3. All Hoffmann-La Roche studies →
- Long Term Evaluation of Sevelamer HCl vs. Calcium-based Phosphate Binder in the Treatment of Hyperphosphatemia in Hemodialysis PatientsCompletedNCT01755078Phase 4
Sponsor listed in the registry: Chugai Pharma Taiwan · First submitted after Chugai Pharma Taiwan became part of Hoffmann-La Roche
- Extension Study of Tocilizumab Long Term Treatment of Moderate to Severe Rheumatoid Arthritis PatientsCompletedNCT01347983Phase 3
Sponsor listed in the registry: Chugai Pharma Taiwan · First submitted after Chugai Pharma Taiwan became part of Hoffmann-La Roche
- Study of Tocilizumab in Combination With Methotrexate for Treatment of Moderate to Severe Rheumatoid Arthritis PatientsCompletedNCT01258712Phase 3
Sponsor listed in the registry: Chugai Pharma Taiwan · First submitted after Chugai Pharma Taiwan became part of Hoffmann-La Roche